It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
With supply more abundant, U.S. pharmacies struggle to use up COVID pills

World / Science & Health Apr 27, 2022

With supply more abundant, U.S. pharmacies struggle to use up COVID pills

by Noah Weiland

The rollout of the COVID-19 treatment Paxlovid has been far more complicated and less efficient than expected, leaving hundreds of thousands of courses unused.

U.S. in talks with Japan's Shionogi to buy new COVID-19 pill

Business / Corporate Apr 22, 2022

U.S. in talks with Japan's Shionogi to buy new COVID-19 pill

Shionogi's treatment is in late-stage clinical trials and hasn’t yet been authorized, but in earlier studies, it reduced viral loads in patients within the first few days of use.

Shionogi to recommend pregnant women not use oral COVID drug

National Apr 13, 2022

Shionogi to recommend pregnant women not use oral COVID drug

Shionogi has filed for conditional early approval to skip the final stage of clinical trials once a certain level of efficacy and safety has been confirmed.

India hopes ‘Pharma City’ will break China’s grip on industry

World / Science & Health Apr 12, 2022

India hopes ‘Pharma City’ will break China’s grip on industry

by Chris Kay and Malavika Kaur Makol

It’s a vast project that shows how governments are growing increasingly concerned about China’s stranglehold over drug supplies — as well as the challenges they face in loosening it.

Japan looks to accelerate vaccine research and development with new government body

National / Science & Health | FOCUS Apr 3, 2022

Japan looks to accelerate vaccine research and development with new government body

by Takaki Tominaga

The government also aims to contribute to the international community by making the vaccines produced in Japan available abroad.

World moves from shortages to possible glut of COVID-19 vaccines

World Mar 29, 2022

World moves from shortages to possible glut of COVID-19 vaccines

by Chris Kay and Malavika Kaur Makol

Even as boosters are likely to keep demand alive for COVID-19 inoculations worldwide, the desperate shortages that existed for much of last year have waned.

Shionogi signs supply deal with Japanese government for COVID-19 pill

Business / Corporate Mar 25, 2022

Shionogi signs supply deal with Japanese government for COVID-19 pill

The government is considering buying a million doses of the drug, pending regulatory approval.

With sumo flag sponsorship deal, COVID vaccine-maker Moderna reveals Japan ambition

Business / Corporate Mar 23, 2022

With sumo flag sponsorship deal, COVID vaccine-maker Moderna reveals Japan ambition

by Rocky Swift

The U.S. firm is seeking to build on its newfound renown in COVID-19 vaccines and wrestle market share from compatriot Pfizer Inc.

U.S., EU, India and South Africa near deal on intellectual property waiver for COVID vaccines

World Mar 16, 2022

U.S., EU, India and South Africa near deal on intellectual property waiver for COVID vaccines

The tentative agreement does not include COVID-19 treatments or tests, and also has limitations likely to exclude China from any waiver, according to one source.

Pfizer asks U.S. regulator to clear another booster for older adults

World / Science & Health Mar 16, 2022

Pfizer asks U.S. regulator to clear another booster for older adults

The drugmaker and its partner BioNTech have submitted data to the FDA from Israel, which began offering a fourth shot to older people and health care workers last year.

Drugmakers pause trials in Russia while still sending medicine

Business Mar 15, 2022

Drugmakers pause trials in Russia while still sending medicine

by Riley Griffin and Robert Langreth

Major pharmaceutical firms are seeking to strike a balance between international opprobrium over Russia’s invasion of Ukraine and the needs of sick patients.

Fujifilm to halt enrollment in Avigan trial for COVID-19

National Mar 11, 2022

Fujifilm to halt enrollment in Avigan trial for COVID-19

The emergence of the omicron variant, which usually causes milder infections, made it tough to determine the drug's effectiveness in preventing severe symptoms, the company said.

« 1 … 7 8 9 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times